Problem of living liver donation in the absence of deceased liver transplantation program: Mansoura experience

Table 2 Number and ratio for each reason of donor exclusion during phase I of the living donor evaluation protocol

Phase	Step	n	Exclusion	n	% from the step
Phase I	Confirmation of the relative	1004	Non-related donor	2	0.19
	Age	1002	Over age limit	223	22.25
	BMI	779	Overweight	26	3.33
			Underweight	5	0.64
	Clinical evaluation	748	Uncontrolled HTN	2	0.26
	Initial surgical evaluation	746	Upper abdominal surgery	6	0.8
	Psychological evaluation	740	Algophobia	1	0.13
			Hesitation	3	0.4
	ABO compatibility	736	ABO incompatibility	102	13.85
		634	Withdrawal	23	3.62
	CBC and biochemistry	611	thrombocytopenia	3	0.49
			uncontrolled DM	4	0.65
			elevated liver enzymes	7	1.14
			hyperbilirubinemia	2	0.32
			hypoalbuminemia	1	0.16
		594	Family refusal	5	0.84
			Withdrawal	6	1.01
	Pregnancy test	583	Positive test	16	2.74
	Abdominal US	567	Splenomegaly	1	0.17
			Fatty liver	1	0.17
		565	Withdrawal	29	5.13
	Serological assessment	536	HCV positive	39	7.27
			HBV positive	34	6.34
			CMV positive	7	1.3
			EBV positive	1	0.18
			HCV and HBV positive	6	1.11
			HCV and CMV positive	1	0.18
		448	Withdrawal	9	2.0
	Anesthetic reassessment	439	Smoker	28	6.37
			IHD	2	0.45
			Rheumatic heart disease	3	0.68
			Valvular heart disease	3	0.68
			Atrial ectopics	1	0.22
		402	Withdrawal	31	7.71

HCV: Hepatitis C virus; HBV: Hepatitis B virus; CMV: Cytomegalovirus.